1. (valid email required)
 

cforms contact form by delicious:days

Healthcare

Our Healthcare investments include device, distribution and service companies focused on the healthcare industry. A few of our portfolio companies are profiled below.

Advanced Practice Strategies

Headquartered in Boston, Advanced Practice Strategies is a national leader in innovative, instructional solutions promoting patient safety, jury education and medical risk management.  The APS eLearning division offers web-based training to physicians and nurses, designed to reduce medical error and increase patient safety.  The curriculum is based on real world experience from thousands of medical malpractice claims through work with a variety of hospitals and insurers, including Risk Management Foundation of the Harvard Medical Institutions and other leading players.  The APS eLearning programs have been proven to help hospitals and clinicians significantly reduce risk and enhance patient safety across the country.  APS is also a pioneer leader in the field of demonstrative evidence for the courtroom.  The Company has built a reputation for providing expert, strategic counsel as well as high quality medical illustrations, helping clients to achieve a 97 percent win rate for tried cases. Mass Capital invested in APS to support the Company’s rapid growth.

Visit Website: www.aps-web.com.

MicroCal

MicroCal was founded in 1977 with the mission to develop, manufacture and market ultrasensitive calorimeters.  Prior to the formation of MicroCal, commercial calorimeters were extremely difficult to use, had long experimental times and required large amounts of sample due to poor sensitivity.  As a result, the use of microcalorimetry was limited almost exclusively to specialists who devoted themselves primarily to calorimetry.  Over the past thirty years, MicroCal has been privileged to participate in the development and advancement of an important technology that has found broad application in the basic research of biomolecules and the discovery and development of many new therapeutics and biotherapeutics. There are over 7,900 peer reviewed publications that include data collected on MicroCal products.  Mass Capital provided MicroCal with mezzanine capital that was used to support a recapitalization led by Riverside Partners.

Visit Website: www.microcal.com